Investors & Media

Corporate Governance


International Stem Cell Corporation (ISCO) is a publicly traded biotechnology company with a powerful new stem cell technology called human parthenogenetic activation that promises to significantly advance the field of regenerative medicine.
Andrey Semechkin, PhD., Chief Executive Officer

 

 
 

Committee Composition


  Audit Committee Compensation Committee Governance Committee
 
Independent Directors
Donald Wright
Paul Maier
Inside Directors
Andrey Semechkin, PhD.  
Russell Kern, PhD.